BIOMAT Database Logo BIOMAT Database Logo

[The question of adverse effects of clofibrate. Experience in patients with diabetes mellitus]. 1976

C Häser, and V Rahlfs, and H Mehnert

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

C Häser, and V Rahlfs, and H Mehnert
[Treatment of diabetes mellitus with clofibrate].
July 1972, Polski tygodnik lekarski (Warsaw, Poland : 1960),
C Häser, and V Rahlfs, and H Mehnert
Serious adverse effects with clofibrate.
October 1980, The New Zealand medical journal,
C Häser, and V Rahlfs, and H Mehnert
[Clofibrate in the treatment of diabetes mellitus].
January 1978, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
C Häser, and V Rahlfs, and H Mehnert
[Combined clofibrate-chlorpropamide therapy in diabetes insipidus complicated with diabetes mellitus].
August 1975, Endokrinologie,
C Häser, and V Rahlfs, and H Mehnert
The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
November 1987, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
C Häser, and V Rahlfs, and H Mehnert
Treatment of diabetes insipidus complicated by diabetes mellitus with chlorpropamide and clofibrate.
August 1980, Klinische Wochenschrift,
C Häser, and V Rahlfs, and H Mehnert
The question of cardiomyopathy in diabetes mellitus.
December 1978, Annals of internal medicine,
C Häser, and V Rahlfs, and H Mehnert
[Experience with the treatment of fractures in patients with diabetes mellitus].
August 1985, Ortopediia travmatologiia i protezirovanie,
C Häser, and V Rahlfs, and H Mehnert
[Current data on adverse effects of clofibrate].
January 1980, Polski tygodnik lekarski (Warsaw, Poland : 1960),
C Häser, and V Rahlfs, and H Mehnert
[Experience in the use of diosponin in patients with diabetes mellitus].
January 1970, Problemy endokrinologii,
Copied contents to your clipboard!